尼古丁戒断综合征的性别差异及其神经生物学机制
Gender-Dependent Effects and Neurobiological Mechanisms in Nicotine Withdrawal Syndrome
摘要: 烟草成瘾至今仍是世界上许多国家主要的可预防的死亡和残疾原因,而尼古丁戒断症状是成瘾后戒烟率低,复吸率高的重要原因。本文将回顾尼古丁戒断症状在行为表现上的性别差异,并从激素和神经递质系统两个层面来分析这种性别差异的神经生物学机制。综合实验研究发现了,女性通常比男性有更严重的戒断症状,更难以戒烟,而戒烟后产生更强烈的焦虑或抑郁情绪是女性更容易复吸的重要原因。从激素层面上分析,女性的HPA轴对环境变化更加敏感,戒断会引起更大强度的应答,使得女性的焦虑程度更重,也更容易感受到压力而复吸;此外孕酮可能会在一定程度上缓解戒断后HPA轴激素增加引起的焦虑情绪,而雌二醇的增加会加重负面情绪,所以推测女性在生殖周期中的卵泡期复吸的可能性更大。从递质系统水平分析,发现烟碱乙酰胆碱受体(nACHRs) β2亚基主要促进了男性中尼古丁戒断症状的形成,α5亚基主要在女性的尼古丁戒断中起抑制作用;而多巴胺系统在其中的调控作用更加复杂。文献研究表明,将性别作为尼古丁戒断症状研究中的一个因素将提高我们在个性化戒烟项目中的成功率。
Abstract: Tobacco addiction remains a major cause of preventable death and disability in many countries of the world, and nicotine withdrawal syndrome is important reason for low rate of smoking cessation and high rate of relapse. This paper will review the sex differences in behavioral manifestations of nicotine withdrawal syndrome and analyze the neurobiological mechanisms of this gender difference from the perspectives of hormone and neurotransmitter systems. A combination of experimental studies has found that women tend to have more severe withdrawal symptoms than men and are less likely to quit smoking, and that higher levels of anxiety or depression after quitting smoking may explain why women are more likely to relapse. From the perspective of hormones, women's HPA axis is more sensitive to environmental changes. Withdrawal will cause a stronger response, which makes women more anxious and more likely to feel pressure and relapse. In addition, progesterone may relieve the anxiety caused by the increase of HPA axis hormone after withdrawal to a certain extent, while the increase of estradiol will aggravate the negative emotions, so women are more likely to relapse during the follicular phase of the reproductive cycle. At the transmitter system level, the nicotinic acetylcholine receptor (nACHRs) 2 subunit was found to promote nicotine withdrawal symptoms in males, and the 5 subunit was found to inhibit nicotine withdrawal in females. The role of the dopamine system is more complex. The literature suggests that using gender as a factor in nicotine withdrawal symptoms research will improve our success rate in personalized cessation programs.
文章引用:王雪娇 (2021). 尼古丁戒断综合征的性别差异及其神经生物学机制. 心理学进展, 11(1), 249-257. https://doi.org/10.12677/AP.2021.111028

参考文献

[1] al’Absi, M. (2006). Hypothalamic-Pituitary-Adrenocortical Responses to Psychological Stress and Risk for Smoking Re-lapse. International Journal of Psychophysiology, 59, 218-227.[CrossRef] [PubMed]
[2] Allen, A. M., Allen, S. S., Lunos, S., & Pomerleau, C. S. (2010). Severity of Withdrawal Symptomatology in Follicular Versus Luteal Quitters: The Combined Effects of Menstrual Phase and Withdrawal on Smoking Cessation Outcome. Addictive Behaviors, 35, 549-552.[CrossRef] [PubMed]
[3] Allen, S. S., Allen, A. M., Lunos, S., & Hatsukami, D. K. (2009). Patterns of Self-Selected Smoking Cessation Attempts and Relapse by Menstrual Phase. Addictive Behaviors, 34, 928-931.[CrossRef] [PubMed]
[4] Allen, S. S., Hatsukami, D. K., & Christianson, D. (2003). Nicotine Withdrawal and Depressive Symptomatology during Short-Term Smoking Abstinence: A Comparison of Postmenopausal Women Using and Not Using Hormone Replacement Therapy. Nicotine & Tobacco Research, 5, 49-59.
[5] Ashare, R. L., & McKee, S. A. (2012). Effects of Varenicline and Bupropion on Cognitive Processes among Nicotine-Deprived Smokers. Experimental and Clinical Psychopharmacology, 20, 63-70.[CrossRef] [PubMed]
[6] Battle, D. E. (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM). Codas, 25, 191-192.
[7] Becker, J. B., & Koob, G. F. (2016). Sex Differences in Animal Models: Focus on Addiction. Pharmacological Reviews, 68, 242-263.[CrossRef] [PubMed]
[8] Benowitz, N. L. (1999). Nicotine Addiction. Primary Care, 26, 611-631.[CrossRef
[9] Caldarone, B. J., King, S. L., & Picciotto, M. R. (2008). Sex Differences in Anxiety-Like Behavior and Locomotor Activity Following Chronic Nicotine Exposure in Mice. Neuroscience Letters, 439, 187-191.[CrossRef] [PubMed]
[10] Carcoba, L. M., Flores, R. J., Natividad, L. A., & O’Dell, L. E. (2018). Amino Acid Modulation of Dopamine in the Nucleus Accumbens Mediates Sex Differences in Nicotine Withdrawal. Addiction Biology, 23, 1046-1054.[CrossRef] [PubMed]
[11] Concas, A., Sogliano, C., Porcu, P., Marra, C., Brundu, A., & Biggio, G. (2006). Neurosteroids in Nicotine and Morphine Dependence. Psychopharmacology (Berl), 186, 281-292.[CrossRef] [PubMed]
[12] Correa, V. L., Flores, R. J., Carcoba, L. M., Arreguin, M. C., & O’Dell, L. E. (2019). Sex Differences in Cholinergic Systems in the Interpeduncular Nucleus Following Nicotine Exposure and Withdrawal. Neuropharmacology, 158, Article ID: 107714.[CrossRef] [PubMed]
[13] Cosgrove, K. P., Esterlis, I., McKee, S. A., Bois, F., Seibyl, J. P., Mazure, C. M. et al. (2012). Sex Differences in Availability of β2*-Nicotinic Acetylcholine Receptors in Recently Abstinent Tobacco Smokers. Archives of General Psychiatry, 69, 418-427.[CrossRef] [PubMed]
[14] Czoty, P. W., Riddick, N. V., Gage, H. D., Sandridge, M., Nader, S. H., Garg, S. et al. (2009). Effect of Menstrual Cycle Phase on Dopamine D2 Receptor Availability in Female Cynomolgus Monkeys. Neuropsychopharmacology, 34, 548-554.[CrossRef] [PubMed]
[15] Dani, J. A., & De Biasi, M. (2001). Cellular Mechanisms of Nicotine Addiction. Pharmacology Biochemistry & Behavior, 70, 439-446.[CrossRef
[16] DeVito, E. E., Herman, A. I., Waters, A. J., Valentine, G. W., & Sofuoglu, M. (2014). Subjective, Physiological, and Cognitive Responses to Intravenous Nicotine: Effects of Sex and Menstrual Cycle Phase. Neuropsychopharmacology, 39, 1431-1440.[CrossRef] [PubMed]
[17] Faraday, M. M., Blakeman, K. H., & Grunberg, N. E. (2005). Strain and Sex Alter Effects of Stress and Nicotine on Feeding, Body Weight, and HPA Axis Hormones. Pharmacology Biochemistry & Behavior, 80, 577-589.[CrossRef] [PubMed]
[18] Faulkner, P., Petersen, N., Ghahremani, D. G., Cox, C. M., Tyndale, R. F., Hellemann, G. S., & London, E. D. (2018). Sex Differences in Tobacco Withdrawal and Responses to Smoking Reduced-Nicotine Cigarettes in Young Smokers. Psychopharmacology (Berl), 235, 193-202.[CrossRef] [PubMed]
[19] Fluharty, M., Taylor, A. E., Grabski, M., & Munafo, M. R. (2017). The Association of Cigarette Smoking with Depression and Anxiety: A Systematic Review. Nicotine & Tobacco Research, 19, 3-13.[CrossRef] [PubMed]
[20] Gentile, N. E., Andrekanic, J. D., Karwoski, T. E., Czambel, R. K., Rubin, R. T., & Rhodes, M. E. (2011). Sexually Diergic Hypothalamic-Pituitary-Adrenal (HPA) Responses to Single-Dose Nicotine, Continuous Nicotine Infusion, and Nicotine Withdrawal by Mecamylamine in Rats. Brain Research Bulletin, 85, 145-152.[CrossRef] [PubMed]
[21] Hamilton, K. R., Berger, S. S., Perry, M. E., & Grunberg, N. E. (2009). Behavioral Effects of Nicotine Withdrawal in Adult Male and Female Rats. Pharmacology Biochemistry & Behavior, 92, 51-59.[CrossRef] [PubMed]
[22] Hamilton, K. R., Perry, M. E., Berger, S. S., & Grunberg, N. E. (2010). Behavioral Effects of Nicotine Withdrawal Differ by Genetic Strain in Male and Female Adolescent Rats. Nicotine & Tobacco Research, 12, 1236-1245.[CrossRef] [PubMed]
[23] Heishman, S. J. (1999). Behavioral and Cognitive Effects of Smoking: Relationship to Nicotine Addiction. Nicotine & Tobacco Research, 1, S143-S147.[CrossRef] [PubMed]
[24] Koylu, E., Demirgoren, S., London, E. D., & Pogun, S. (1997). Sex Difference in Up-Regulation of Nicotinic Acetylcholine Receptors in Rat Brain. Life Sciences, 61, PL185-PL190.[CrossRef
[25] Liao, Y., Wu, Q., Kelly, B. C., Zhang, F., Tang, Y. Y., Wang, Q. et al. (2018). Effectiveness of a Text-Messaging-Based Smoking Cessation Intervention (“Happy Quit”) for Smoking Cessation in China: A Randomized Controlled Trial. PLoS Medicine, 15, e1002713.[CrossRef] [PubMed]
[26] Liu, X., Bragg, F., Yang, L., Kartsonaki, C., Guo, Y., Du, H. et al. (2018). Smoking and Smoking Cessation in Relation to Risk of Diabetes in Chinese Men and Women: A 9-Year Prospective Study of 0.5 Million People. The Lancet Public Health, 3, e167-e176.[CrossRef
[27] Lynch, W. J., Roth, M. E., & Carroll, M. E. (2002). Biological Basis of Sex Differences in Drug Abuse: Preclinical and Clinical Studies. Psychopharmacology (Berl), 164, 121-137.[CrossRef] [PubMed]
[28] McClernon, F. J., Kollins, S. H., Lutz, A. M., Fitzgerald, D. P., Murray, D. W., Redman, C., & Rose, J. E. (2008). Effects of Smoking Abstinence on Adult Smokers with and without Attention Deficit Hyperactivity Disorder: Results of a Preliminary Study. Psychopharmacology (Berl), 197, 95-105.[CrossRef] [PubMed]
[29] McQueen, J. K., Wilson, H., Sumner, B. E., & Fink, G. (1999). Serotonin Transporter (SERT) mRNA and Binding Site Densities in Male Rat Brain Affected by Sex Steroids. Molecular Brain Research, 63, 241-247.[CrossRef
[30] Merritt, P. S., Cobb, A. R., & Cook, G. I. (2012). Sex Differences in the Cognitive Effects of Tobacco Abstinence: A Pilot Study. Experimental and Clinical Psychopharmacology, 20, 258-263.[CrossRef] [PubMed]
[31] Myers, C. S., Taylor, R. C., Moolchan, E. T., & Heishman, S. J. (2008). Dose-Related Enhancement of Mood and Cognition in Smokers Administered Nicotine Nasal Spray. Neuropsychopharmacology, 33, 588-598.[CrossRef] [PubMed]
[32] Pang, R. D., Liautaud, M. M., Kirkpatrick, M. G., Huh, J., Monterosso, J., & Leventhal, A. M. (2018). Ovarian Hormones and Transdermal Nicotine Administration Independently and Synergistically Suppress Tobacco Withdrawal Symptoms and Smoking Reinstatement in the Human Laboratory. Neuropsychopharmacology, 43, 828-837.[CrossRef] [PubMed]
[33] Pauly, J. R. (2008). Gender Differences in Tobacco Smoking Dynamics and the Neuropharmacological Actions of Nicotine. Frontiers in Bioscience, 13, 505-516.[CrossRef] [PubMed]
[34] Perkins, K. A., & Scott, J. (2008). Sex Differences in Long-Term Smoking Cessation Rates Due to Nicotine Patch. Nicotine & Tobacco Research, 10, 1245-1250.[CrossRef] [PubMed]
[35] Poltavski, D. V., Petros, T. V., & Holm, J. E. (2012). Lower but Not Higher Doses of Transdermal Nicotine Facilitate Cognitive Performance in Smokers on Gender Non-Preferred Tasks. Pharmacology Biochemistry & Behavior, 102, 423-433.[CrossRef] [PubMed]
[36] Ribeiro-Carvalho, A., Lima, C. S., Nunes-Freitas, A. L., Filgueiras, C. C., Manhaes, A. C., & Abreu-Villaca, Y. (2011). Exposure to Nicotine and Ethanol in Adolescent Mice: Effects on Depressive-Like Behavior during Exposure and Withdrawal. Behavioural Brain Research, 221, 282-289.[CrossRef] [PubMed]
[37] Schnoll, R. A., Patterson, F., & Lerman, C. (2007). Treating Tobacco Dependence in Women. Journal of Women’s Health (Larchmt), 16, 1211-1218.[CrossRef] [PubMed]
[38] Simmons, S. J., & Gould, T. J. (2014). Involvement of Neuronal Beta2 Subunit-Containing Nicotinic Acetylcholine Receptors in Nicotine Reward and Withdrawal: Implications for Pharmacotherapies. Journal of Clinical Pharmacy and Therapeutics, 39, 457-467.[CrossRef] [PubMed]
[39] Staley, J. K., Krishnan-Sarin, S., Zoghbi, S., Tamagnan, G., Fujita, M., Seibyl, J. P. et al. (2001). Sex Differences in [123I]Beta-CIT SPECT Measures of Dopamine and Serotonin Transporter Availability in Healthy Smokers and Nonsmokers. Synapse, 41, 275-284.[CrossRef] [PubMed]
[40] Tidey, J. W., & Miller, M. E. (2015). Smoking Cessation and Reduction in People with Chronic Mental Illness. BMJ, 351, h4065.[CrossRef] [PubMed]
[41] Torres, O. V., Gentil, L. G., Natividad, L. A., Carcoba, L. M., & O’Dell, L. E. (2013). Behavioral, Biochemical, and Molecular Indices of Stress Are Enhanced in Female Versus Male Rats Experiencing Nicotine Withdrawal. Frontiers in Psychiatry, 4, 38.[CrossRef] [PubMed]
[42] Torres, O. V., Pipkin, J. A., Ferree, P., Carcoba, L. M., & O’Dell, L. E. (2015). Nicotine Withdrawal Increases Stress-Associated Genes in the Nucleus Accumbens of Female Rats in A Hormone-Dependent Manner. Nicotine & Tobacco Research, 17, 422-430.[CrossRef] [PubMed]
[43] Weinberger, A. H., Maciejewski, P. K., McKee, S. A., Reutenauer, E. L., & Mazure, C. M. (2009). Gender Differences in Associations between Lifetime Alcohol, Depression, Panic Disorder, and Posttraumatic Stress Disorder and Tobacco Withdrawal. American Journal on Addictions, 18, 140-147.[CrossRef] [PubMed]
[44] Weinberger, A. H., Platt, J. M., Shuter, J., & Goodwin, R. D. (2016). Gender Differences in Self-Reported Withdrawal Symptoms and Reducing or Quitting Smoking Three Years Later: A Prospective, Longitudinal Examination of U.S. Adults. Drug and Alcohol Dependence, 165, 253-259.[CrossRef] [PubMed]
[45] Wetherill, R. R., Franklin, T. R., & Allen, S. S. (2016). Ovarian Hormones, Menstrual Cycle Phase, and Smoking: A Review with Recommendations for Future Studies. Current Addiction Reports, 3, 1-8.[CrossRef] [PubMed]
[46] Xu, J., Azizian, A., Monterosso, J., Domier, C. P., Brody, A. L., Fong, T. W., & London, E. D. (2008). Gender Effects on Mood and Cigarette Craving during Early Abstinence and Resumption of Smoking. Nicotine & Tobacco Research, 10, 1653-1661.[CrossRef] [PubMed]